LegalView.com would like to inform readers of its newly launched information portal dealing with the possibly unsafe prescription drugs Dostinex and Risperdal. Each of these information portals ...
Johnson & Johnson (NYSE:JNJ) says it has settled most of the lawsuits in the anti-psychotic drug Risperdal cases and has recorded $800 million in expenses in connection with the agreement. The medical ...
Max 50mg every 2 weeks. Renal or hepatic impairment: if total daily dose of at least 2mg of oral risperidone tolerated, may give 12.5mg or 25mg IM every 2 weeks. History of poor tolerability to ...
WASHINGTON (Reuters) - The U.S. Supreme Court rejected a bid by Johnson & Johnson to overturn a $70 million jury verdict against the pharmaceutical company for its failure to warn about risks ...
J&J to Pay $2.2B Settlement to End Risperdal Probes New Brunswick, N.J.-based Johnson & Johnson has agreed to pay up to $2.2 billion to settle U.S. investigations and lawsuits regarding its marketing ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the past, today announced it has dosed the first participant ...
NEW YORK--(BUSINESS WIRE)--Attorney Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that four young men prescribed the antipsychotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback